Mattis Says U.S. Ready to Ink Defense Technology Pact With India
(Bloomberg) -- U.S. Defense Secretary Jim Mattis said he's ready to sign a key defense cooperation agreement with India, as tensions remained over threatened American sanctions.
The talks, postponed from earlier, are scheduled for Thursday as the U.S. threatens economic sanctions on Prime Minister Narendra Modi's government unless it significantly reduces purchase of oil from Iran and scraps the purchase of an anti-aircraft missile system from Russia. India has so far refused to agree to the demands.
"We are pretty much there already on the American side," Mattis told traveling reporters. "We'll see where they're at."
The U.S. hopes to sign the proposed pact that will allow sharing more sensitive defense technologies with India, Mattis said, declining to give more details. The Communications Interoperability and Security Memorandum of Agreement will be a key part of the so-called 2+2 meetings between Mattis, U.S. Secretary of State Mike Pompeo and their Indian counterparts due Thursday.
Defense Minister Nirmala Sitharaman and Foreign Minister Sushma Swaraj will present the Indian side at the talks.
Mattis added that the two sides will likely discuss India's planned purchase of S-400 anti-aircraft missiles from Russia.
"Freedom means that at times nations don't agree with each other -- that doesn't mean we can't be partners," Mattis said.
--With assistance from Iain Marlow.
To contact the reporter on this story: Tony Capaccio in New Delhi at acapaccio@bloomberg.net
To contact the editors responsible for this story: Ruth Pollard at rpollard2@bloomberg.net, Unni Krishnan, Daniel Ten Kate
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.